These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 19597368

  • 21. Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia.
    Skulas-Ray AC, West SG, Davidson MH, Kris-Etherton PM.
    Expert Opin Pharmacother; 2008 May; 9(7):1237-48. PubMed ID: 18422480
    [Abstract] [Full Text] [Related]

  • 22. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW.
    Curr Med Res Opin; 2001 May; 17(1):60-73. PubMed ID: 11464448
    [Abstract] [Full Text] [Related]

  • 23. L-Arginine enhances the triglyceride-lowering effect of simvastatin in patients with elevated plasma triglycerides.
    Schulze F, Glos S, Petruschka D, Altenburg C, Maas R, Benndorf R, Schwedhelm E, Beil U, Böger RH.
    Nutr Res; 2009 May; 29(5):291-7. PubMed ID: 19555809
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
    McKenney JM, Sica D.
    Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
    [Abstract] [Full Text] [Related]

  • 27. A randomized placebo-controlled double-blind trial of lipid-lowering strategies in patients with renal insufficiency: diet modification with or without fenofibrate.
    Levin A, Duncan L, Djurdjev O, Shapiro RJ, Frohlich J, Belanger A, Dumas R, Ross S.
    Clin Nephrol; 2000 Feb; 53(2):140-6. PubMed ID: 10711416
    [Abstract] [Full Text] [Related]

  • 28. Prescription omega-3 acid ethyl esters plus simvastatin 20 and 80 mg: effects in mixed dyslipidemia.
    Maki KC, Lubin BC, Reeves MS, Dicklin MR, Harris WS.
    J Clin Lipidol; 2009 Feb; 3(1):33-8. PubMed ID: 21291786
    [Abstract] [Full Text] [Related]

  • 29. Rosuvastatin and fenofibrate alone and in combination in type 2 diabetes patients with combined hyperlipidaemia.
    Durrington PN, Tuomilehto J, Hamann A, Kallend D, Smith K.
    Diabetes Res Clin Pract; 2004 May; 64(2):137-51. PubMed ID: 15063607
    [Abstract] [Full Text] [Related]

  • 30. The effect of n - 3 PUFA/gamma-cyclodextrin complex on serum lipids in healthy volunteers--a randomized, placebo-controlled, double-blind trial.
    Kobayashi K, Hamazaki K, Fujioka S, Terao K, Yamamoto J, Kobayashi S.
    Asia Pac J Clin Nutr; 2007 May; 16(3):429-34. PubMed ID: 17704023
    [Abstract] [Full Text] [Related]

  • 31. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR.
    Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
    [Abstract] [Full Text] [Related]

  • 32. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 33. Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: a phase 3, randomized, controlled study.
    Mohiuddin SM, Pepine CJ, Kelly MT, Buttler SM, Setze CM, Sleep DJ, Stolzenbach JC.
    Am Heart J; 2009 Jan; 157(1):195-203. PubMed ID: 19081418
    [Abstract] [Full Text] [Related]

  • 34. Correlation of non-high-density lipoprotein cholesterol and low-density lipoprotein cholesterol with apolipoprotein B during simvastatin + fenofibrate therapy in patients with combined hyperlipidemia (a subanalysis of the SAFARI trial).
    Grundy SM, Vega GL, Tomassini JE, Tershakovec AM.
    Am J Cardiol; 2009 Aug 15; 104(4):548-53. PubMed ID: 19660610
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 15; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 36. Fenofibrate reduces lipoprotein associated phospholipase A2 mass and oxidative lipids in hypertriglyceridemic subjects with the metabolic syndrome.
    Rosenson RS.
    Am Heart J; 2008 Mar 15; 155(3):499.e9-16. PubMed ID: 18294485
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Rosenstock J, Brazg R, Andryuk PJ, Lu K, Stein P, Sitagliptin Study 019 Group.
    Clin Ther; 2006 Oct 15; 28(10):1556-68. PubMed ID: 17157112
    [Abstract] [Full Text] [Related]

  • 38. Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial.
    Stroes ESG, Susekov AV, de Bruin TWA, Kvarnström M, Yang H, Davidson MH.
    J Clin Lipidol; 2018 Oct 15; 12(2):321-330. PubMed ID: 29289538
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of micronised fenofibrate in a randomised double-blind study comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia.
    Krempf M, Rohmer V, Farnier M, Issa-Sayegh M, Corda C, Sirugue I, Gerlinger C, Masseyeff-Elbaz MF.
    Diabetes Metab; 2000 May 15; 26(3):184-91. PubMed ID: 10880891
    [Abstract] [Full Text] [Related]

  • 40. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.
    Kostapanos MS, Milionis HJ, Filippatos TD, Nakou ES, Bairaktari ET, Tselepis AD, Elisaf MS.
    Clin Ther; 2007 Jul 15; 29(7):1403-14. PubMed ID: 17825691
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.